Mukai Masaya, Oida Yasuhisa, Mukoyama Sayuri, Okamoto Yuuichi, Ito Isao, Nakasaki Hisao, Kawai Kenji, Sato Shinkichi, Makuuchi Hiroyasu
Department of Surgery, Tokai University Oiso Hospital, Oiso, Kanagawa 259-0198, Japan.
Oncol Rep. 2002 Nov-Dec;9(6):1339-43. doi: 10.3892/or.9.6.1339.
A patient was diagnosed as having subacute ileus due to advanced cancer of the descending colon with multiple liver metastases and was treated by palliative left hemicolectomy. He was considered to have Stage IV cancer based on the finding of extensive peritoneal dissemination. Histopathological examination showed that the tumor was moderately differentiated adenocarcinoma. Postoperative palliative chemotherapy was given with 5-FU and LV twice a month as 1 course, and he received a total of 3 courses. As a result, the multiple liver metastases were completely eliminated. However, his liver metastases recurred, so CPT-11 was added to 5-FU and LV for another 3 courses. When bilateral pleural effusions developed about 1 year postoperatively, CPT-11 was changed to CDGP. Jaundice and massive ascites eventually developed, and he died about 1 year and 5 months postoperatively.
一名患者因降结肠癌伴多发肝转移进展被诊断为亚急性肠梗阻,并接受了姑息性左半结肠切除术。基于广泛腹膜播散的发现,他被认为患有IV期癌症。组织病理学检查显示肿瘤为中分化腺癌。术后给予姑息性化疗,5-氟尿嘧啶和亚叶酸钙每月两次作为1个疗程,他总共接受了3个疗程。结果,多发肝转移完全消失。然而,他的肝转移复发,因此在5-氟尿嘧啶和亚叶酸钙中加入伊立替康再进行3个疗程。术后约1年出现双侧胸腔积液时,将伊立替康改为顺铂。最终出现黄疸和大量腹水,他在术后约1年零5个月死亡。